PowerPanel – Quality vs. Productivity, the Sterile Processing Battle Royale

The panel discussion, sponsored by Censis Technologies, delves into the ongoing debate surrounding quality versus productivity within the sterile processing industry. The conversation is moderated by Hank Balch, Founder and President of Beyond Clean, and features experts from the field. The central issue revolves around differing perspectives and disagreements within the industry regarding the balance between these two critical aspects. Discrepancies arise due to various factors, including historical practices, evolving industry standards, and variations in institutional priorities. The challenge lies in finding the right equilibrium between the imperative to boost productivity with a limited workforce while preserving the high standards of quality within sterile processing. This multifaceted debate grapples with how best to measure and quantify these complex elements in the field.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…